These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 10232541)

  • 1. In vitro modulation of microglia motility by glioma cells is mediated by hepatocyte growth factor/scatter factor.
    Badie B; Schartner J; Klaver J; Vorpahl J
    Neurosurgery; 1999 May; 44(5):1077-82; discussion 1082-3. PubMed ID: 10232541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of motility and proliferation of glioma cells by hepatocyte growth factor.
    Yamamoto S; Wakimoto H; Aoyagi M; Hirakawa K; Hamada H
    Jpn J Cancer Res; 1997 Jun; 88(6):564-77. PubMed ID: 9263534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Met and hepatocyte growth factor/scatter factor expression in human gliomas.
    Koochekpour S; Jeffers M; Rulong S; Taylor G; Klineberg E; Hudson EA; Resau JH; Vande Woude GF
    Cancer Res; 1997 Dec; 57(23):5391-8. PubMed ID: 9393765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells.
    Lamszus K; Schmidt NO; Jin L; Laterra J; Zagzag D; Way D; Witte M; Weinand M; Goldberg ID; Westphal M; Rosen EM
    Int J Cancer; 1998 Jan; 75(1):19-28. PubMed ID: 9426685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas.
    Lamszus K; Laterra J; Westphal M; Rosen EM
    Int J Dev Neurosci; 1999; 17(5-6):517-30. PubMed ID: 10571413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.
    Hamasuna R; Kataoka H; Moriyama T; Itoh H; Seiki M; Koono M
    Int J Cancer; 1999 Jul; 82(2):274-81. PubMed ID: 10389763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis.
    Abounader R; Lal B; Luddy C; Koe G; Davidson B; Rosen EM; Laterra J
    FASEB J; 2002 Jan; 16(1):108-10. PubMed ID: 11729097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells.
    Moriyama T; Kataoka H; Hamasuna R; Yoshida E; Sameshima T; Iseda T; Yokogami K; Nakano S; Koono M; Wakisaka S
    Clin Exp Metastasis; 1999; 17(10):873-9. PubMed ID: 11089886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy.
    Li Y; Lal B; Kwon S; Fan X; Saldanha U; Reznik TE; Kuchner EB; Eberhart C; Laterra J; Abounader R
    Cancer Res; 2005 Oct; 65(20):9355-62. PubMed ID: 16230398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
    Hu B; Guo P; Bar-Joseph I; Imanishi Y; Jarzynka MJ; Bogler O; Mikkelsen T; Hirose T; Nishikawa R; Cheng SY
    Oncogene; 2007 Aug; 26(38):5577-86. PubMed ID: 17369861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo.
    Laterra J; Nam M; Rosen E; Rao JS; Lamszus K; Goldberg ID; Johnston P
    Lab Invest; 1997 Apr; 76(4):565-77. PubMed ID: 9111517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.
    Guerin C; Luddy C; Abounader R; Lal B; Laterra J
    Biochem Biophys Res Commun; 2000 Jun; 273(1):287-93. PubMed ID: 10873600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.
    Weimar IS; Weijer K; van den Berk PC; Muller EJ; Miranda N; Bakker AQ; Heemskerk MH; Hekman A; de Gast GC; Gerritsen WR
    Br J Cancer; 1999 Sep; 81(1):43-53. PubMed ID: 10487611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
    Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
    Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways.
    Bowers DC; Fan S; Walter KA; Abounader R; Williams JA; Rosen EM; Laterra J
    Cancer Res; 2000 Aug; 60(15):4277-83. PubMed ID: 10945642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells.
    Moriyama T; Kataoka H; Hamasuna R; Yokogami K; Uehara H; Kawano H; Goya T; Tsubouchi H; Koono M; Wakisaka S
    Biochem Biophys Res Commun; 1998 Aug; 249(1):73-7. PubMed ID: 9705834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation.
    Goodwin CR; Lal B; Zhou X; Ho S; Xia S; Taeger A; Murray J; Laterra J
    Cancer Res; 2010 Apr; 70(7):2932-41. PubMed ID: 20233866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of hepatocyte growth factor/scatter factor neutralizing antibodies: inhibition of tumor growth in both autocrine and paracrine hepatocyte growth factor/scatter factor:c-Met-driven models of leiomyosarcoma.
    Gao CF; Xie Q; Zhang YW; Su Y; Zhao P; Cao B; Furge K; Sun J; Rex K; Osgood T; Coxon A; Burgess TL; Vande Woude GF
    Mol Cancer Ther; 2009 Oct; 8(10):2803-10. PubMed ID: 19825800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models.
    Cao B; Su Y; Oskarsson M; Zhao P; Kort EJ; Fisher RJ; Wang LM; Vande Woude GF
    Proc Natl Acad Sci U S A; 2001 Jun; 98(13):7443-8. PubMed ID: 11416216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of hepatocyte growth factor/scatter factor and its receptor c-Met in brain tumors: evidence for a role in progression of astrocytic tumors (Review).
    Moriyama T; Kataoka H; Koono M; Wakisaka S
    Int J Mol Med; 1999 May; 3(5):531-6. PubMed ID: 10202187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.